M Zilkha Nathaniel - Net Worth and Insider Trading

M Zilkha Nathaniel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, M Zilkha Nathaniel owns 3 companies in total, including Amedisys Inc (AMED) , Jazz Pharmaceuticals PLC (JAZZ) , and UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778 (UCI) .

Click here to see the complete history of M Zilkha Nathaniel’s form 4 insider trades.

Insider Ownership Summary of M Zilkha Nathaniel

Ticker	Comapny	Transaction Date	Type of Owner
AMED	Amedisys Inc	2016-06-30	director
JAZZ	Jazz Pharmaceuticals PLC	2007-10-04	director
UCI	UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778	2006-04-05	director

M Zilkha Nathaniel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

M Zilkha Nathaniel Ownership Network

Ownership Network List of M Zilkha Nathaniel

No Data

Ownership Network Relation of M Zilkha Nathaniel

M Zilkha Nathaniel Owned Company Details

What does Amedisys Inc do?

Who are the key executives at Amedisys Inc?

M Zilkha Nathaniel is the director of Amedisys Inc. Other key executives at Amedisys Inc include Chief Accounting Officer Allyson Guidroz , director & President and CEO Richard M Ashworth , and Chief Information Officer Michael Paul North .

Amedisys Inc (AMED) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Amedisys Inc (AMED) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Amedisys Inc (AMED) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Amedisys Inc (AMED)'s detailed insider trading history can be found in Insider Trading Tracker table.

Amedisys Inc Insider Transactions

No Available Data

What does Jazz Pharmaceuticals PLC do?

Who are the key executives at Jazz Pharmaceuticals PLC?

M Zilkha Nathaniel is the director of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include director & Executive Chairman Bruce C Cozadd , SVP & Technical Operations Mary Elizabeth Henderson , and VP & Finance& PAO Patricia Carr .

Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary

Over the past 18 months, M Zilkha Nathaniel made no insider transaction in Jazz Pharmaceuticals PLC (JAZZ). Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 4,293 shares made by Patricia Carr , a net sale of 8,850 shares made by Neena M Patil , and a net sale of 1,658 shares made by Jennifer E. Cook .

In summary, during the past 3 months, insiders sold 2,410 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 0 shares, with a net sale of 2,410 shares. During the past 18 months, 34,900 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 22,900 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Jazz Pharmaceuticals PLC Insider Transactions

No Available Data

What does UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778 do?

Who are the key executives at UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778?

M Zilkha Nathaniel is the director of UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778. Other key executives at UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778 include director & President & CEO Kenneth J Fasola , EVP & CFO Steven P Erwin , and Former Chairman of the Board & other: Former Director Allen F Wise .

UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778 (UCI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778 (UCI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778 (UCI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778 (UCI)'s detailed insider trading history can be found in Insider Trading Tracker table.

UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778 Insider Transactions

No Available Data

M Zilkha Nathaniel Mailing Address

Above is the net worth, insider trading, and ownership report for M Zilkha Nathaniel. You might contact M Zilkha Nathaniel via mailing address: C/o Goldman, Sachs & Co., 85 Broad Street, New York Ny 10004.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.